Bain Capital Life Sciences Investors, LLC Top Holdings and 13F Report (2024) About Bain Capital Life Sciences Investors, LLCInvestment ActivityBain Capital Life Sciences Investors, LLC has $961.18 million in total holdings as of September 30, 2024.Bain Capital Life Sciences Investors, LLC owns shares of 24 different stocks, but just 7 companies or ETFs make up 80% of its holdings.Approximately 1.47% of the portfolio was purchased this quarter.About 1.26% of the portfolio was sold this quarter.This quarter, Bain Capital Life Sciences Investors, LLC has purchased 25 new stocks and bought additional shares in 5 stocks.Bain Capital Life Sciences Investors, LLC sold shares of 1 stock and completely divested from 2 stocks this quarter.Largest Holdings Nuvalent $275,930,414NewAmsterdam Pharma $173,866,956Disc Medicine $88,242,418DIANTHUS THERAPEUTICS INC $82,507,522Savara $61,757,538 Largest New Holdings this Quarter CIDARA THERAPEUTICS INC $7,558,110 Holding Largest Purchases this Quarter CIDARA THERAPEUTICS INC 703,080 shares (about $7.56M)Cabaletta Bio 1,110,924 shares (about $5.24M)Marinus Pharmaceuticals 425,700 shares (about $749.23K)Xilio Therapeutics 781,367 shares (about $615.48K)Annexon 540 shares (about $3.20K) Largest Sales this Quarter Tango Therapeutics 180,655 shares (about $1.39M) Sector Allocation Over TimeMap of 500 Largest Holdings ofBain Capital Life Sciences Investors, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorNUVLNuvalent$275,930,4140.0%2,697,26728.7%MedicalNAMSNewAmsterdam Pharma$173,866,9560.0%10,473,91318.1%MedicalIRONDisc Medicine$88,242,4180.0%1,795,7359.2%MedicalDIANTHUS THERAPEUTICS INC$82,507,5220.0%3,013,4238.6%COMSVRASavara$61,757,5380.0%14,565,4576.4%MedicalPHVSPharvaris$61,178,6160.0%3,303,3816.4%MedicalANNXAnnexon$50,022,508$3,197 ▲0.0%8,449,7485.2%MedicalSLDBSolid Biosciences$28,121,0370.0%4,034,5822.9%MedicalTNGXTango Therapeutics$20,882,462$1,391,044 ▼-6.2%2,712,0082.2%MedicalKYVERNA THERAPEUTICS INC$16,471,3290.0%3,368,3701.7%COMMRSNMersana Therapeutics$16,374,3420.0%8,663,6731.7%MedicalCABACabaletta Bio$13,031,391$5,243,561 ▲67.3%2,760,8881.4%MedicalXFORX4 Pharmaceuticals$11,321,7340.0%16,915,7841.2%MedicalIPSCCentury Therapeutics$9,251,7170.0%5,410,3611.0%MedicalAVIRAtea Pharmaceuticals$8,326,8870.0%2,485,6380.9%MedicalCIDARA THERAPEUTICS INC$7,558,110$7,558,110 ▲New Holding703,0800.8%COM NEWRPIDRapid Micro Biosystems$7,506,7580.0%8,434,5600.8%MedicalCCCCC4 Therapeutics$6,337,8870.0%1,111,9100.7%MedicalSYRSSyros Pharmaceuticals$5,912,825$737 ▲0.0%2,750,1510.6%MedicalNAUTNautilus Biotechnology$5,700,0000.0%2,000,0000.6%MedicalMRNSMarinus Pharmaceuticals$4,740,349$749,232 ▲18.8%2,693,3800.5%MedicalXLOXilio Therapeutics$3,597,282$615,483 ▲20.6%4,566,8170.4%MedicalIVVDInvivyd$1,835,5870.0%1,799,5950.2%MedicalNAMSWNewAmsterdam Pharma$700,0000.0%100,0000.1%MedicalARQTArcutis Biotherapeutics$0$9,585,538 ▼-100.0%00.0%MedicalACRSAclaris Therapeutics$0$1,100,000 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
